NASDAQ: NPCE
Neuropace Inc Stock Ownership - Who owns Neuropace?

Insider buying vs selling

Have Neuropace Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Frank M. FischerDirector2025-06-212,281$10.41
$23.75kBuy
Joseph LacobDirector2025-06-211,080$10.41
$11.24kBuy
Rakhi KumarDirector2025-06-211,440$10.41
$14.99kBuy
URI GeigerDirector2025-06-211,140$10.41
$11.87kBuy
Martha MorrellCHIEF MEDICAL OFFICER2025-06-031,338$13.54
$18.12kSell
Rebecca KuhnCHIEF FINANCIAL OFFICER2025-06-031,337$13.54
$18.10kSell
Rebecca KuhnCHIEF FINANCIAL OFFICER2025-05-27357$12.66
$4.52kSell
Joel BeckerCHIEF EXECUTIVE OFFICER2025-05-271,126$12.66
$14.26kSell
Martha MorrellCHIEF MEDICAL OFFICER2025-05-27357$12.66
$4.52kSell
Martha MorrellCHIEF MEDICAL OFFICER2025-05-203,051$17.99
$54.89kSell

1 of 9

NPCE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NPCE insiders and whales buy or sell their stock.

NPCE Shareholders

What type of owners hold Neuropace Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
URI Geiger27.07%8,877,932$90.29MInsider
Greg Shaw Garfield17.24%5,653,237$57.49MInsider
Accelmed Partners II LP13.52%4,432,948$45.08MInsider
Evan Norton12.33%4,042,657$41.11MInsider
Orbimed Advisors LLC10.59%3,473,199$35.32MInsider
Orbimed Advisors LLC10.39%3,406,335$34.64MInstitution
Polar Capital Holdings PLC9.06%2,972,003$30.23MInstitution
Soleus Capital Management LP7.95%2,608,168$26.53MInstitution
Morgan Stanley7.72%2,530,620$25.74MInstitution
First Light Asset Management LLC4.83%1,584,048$16.11MInstitution

1 of 3

NPCE vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NPCE45.81%54.19%Net SellingNet Selling
CLPT29.27%26.88%Net SellingNet Selling
NNOX23.47%0.00%
PTHL0.12%0.00%
RXST74.11%25.89%Net BuyingNet Buying

Neuropace Stock Ownership FAQ

Who owns Neuropace?

Neuropace (NASDAQ: NPCE) is owned by 72.97% institutional shareholders, 86.31% Neuropace insiders, and 0.00% retail investors. URI Geiger is the largest individual Neuropace shareholder, owning 8.88M shares representing 27.07% of the company. URI Geiger's Neuropace shares are currently valued at $84.52M.

If you're new to stock investing, here's how to buy Neuropace stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.